Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.54 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales
Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo. 
Via MarketBeat
3 Dividend Stocks to Count on No Matter What the Market Does
Dividend stocks often lead to stability in investors' portfolios. Let's look at a few of the best dividend stocks to buy this year. 
Via InvestorPlace
Which Healthcare Stock Is a Compelling Pick for the Long Haul?
Healthcare stocks are especially resilient in times of uncertainty. Let's take a look at three compelling picks. 
Via InvestorPlace
SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?
Here's what prospective investors in Acelyrin and SLRN stock may want to watch out for as the company gears up for its IPO. 
Via InvestorPlace
The 3 Most Undervalued Blue-Chip Stocks to Buy in May 2023
These undervalued blue-chip stocks can weather any storm that may be coming. Consider buying these three picks. 
Via InvestorPlace
Johnson & Johnson Increases Dividend: What Shareholders Need To Know
Johnson & Johnson recently raised its dividend by 5%, and thus it has now raised its dividend for 61 consecutive years. 
Via Talk Markets
Looking At Johnson & Johnson's Recent Unusual Options Activity
 
Via Benzinga
Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading
Kenvue (KVUE) stock is set to start trading on Thursday as the company completes its spinoff from Johnson & Johnson (JNJ). 
Via InvestorPlace
Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment
From HKTDC
Via ACN Newswire
3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows
Believe it or not, Nvidia is one of our blue-chip stocks to buy. It has worked in the past and I suspect it will work again in the future. 
Via InvestorPlace
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
From Johnson & Johnson
Via Business Wire
KVUE Stock: Should You Buy Into the Kenvue IPO?
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business. 
Via InvestorPlace
2 Stocks to Buy With $200 That Can Survive Any Recession
These businesses have an excellent track record of surviving difficult economic times. 
Via The Motley Fool
Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?
Over time, your dividend payments from the stock are likely to rise significantly. 
Via The Motley Fool
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen  
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy in May
These two dividend-paying pharma stocks both screen as significantly undervalued right now. 
Via The Motley Fool
Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical
Both are great companies, but one might be a slightly better option. 
Via The Motley Fool
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS... 
Via Benzinga
The 7 Best Dividend Stocks to Buy for May 2023
Each of these seven dividend stocks to buy has a solid dividend yield, a sustainable payout ratio, and a history of dividend growth. 
Via InvestorPlace
KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?
Johnson & Johnson spinoff Kenvue is gearing up to go public on May 4. Here's what investors need to know about KVUE stock and the Kenvue IPO. 
Via InvestorPlace
If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It
Buffett would probably agree with this choice. 
Via The Motley Fool
7 High-Yield Dividend Stocks to Buy and Hold Forever
A stagnant market can be frustrating, but also a good time to look for high-yield dividend stocks to buy now. 
Via InvestorPlace
2 Simple Ways to Make $40,000 in Passive Income
Make your money work for you with these two investment options. 
Via The Motley Fool
Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April
As April draws to a close, it's the right time to look back at how the 11 S&P 500 sector ETFs fared over the month. The market as a whole was only slightly positive for the month, with the SPDR S&P 500... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.